FKTN and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Moreover, reporting on a new mutation and a putative functional effect can be valuable in understanding pathogenic mechanisms involving FKTN and performing genotype–phenotype correlations in the dystroglycanopathies phenotype spectrum.